File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1159/000186604
- Scopus: eid_2-s2.0-0025951248
- PMID: 1758534
- WOS: WOS:A1991GK33600014
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: 1,25-Dihydroxycholecalciferol and peritoneal macrophage chemotaxis in patients on continuous ambulatory peritoneal dialysis
Title | 1,25-Dihydroxycholecalciferol and peritoneal macrophage chemotaxis in patients on continuous ambulatory peritoneal dialysis |
---|---|
Authors | |
Keywords | 1,25-dihydroxycholecalciferol peritoneal dialysis peritoneal macrophage chemotaxis |
Issue Date | 1991 |
Publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/NEF |
Citation | Nephron, 1991, v. 59 n. 3, p. 434-439 How to Cite? |
Abstract | Single graded doses of 1,25-dihydroxycholecalciferol of 2 and 4 μg were added intraperitoneally into the overnight 1.5% glucose dialysate of 6 patients on continuous ambulatory peritoneal dialysis. The effect on peritoneal macrophage chemotaxis and random migration was studied and compared with the baseline when no 1,25-(OH)2D3 was added. No consistent effect on peritoneal macrophage chemotaxis was observed. Random migration was significantly depressed at 4 μg when compared with baseline (5.4 ± 1.9 vs. 12.2 ± 3.7 cells/high-power field, p < 0.05). The potential clinical role of 1,25-(OH)2D3 as an immune modulator requires further study. |
Persistent Identifier | http://hdl.handle.net/10722/161884 |
ISSN | 2023 SCImago Journal Rankings: 0.774 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, PCK | en_US |
dc.contributor.author | Ip, MSM | en_US |
dc.contributor.author | Pun, KK | en_US |
dc.date.accessioned | 2012-09-05T05:15:48Z | - |
dc.date.available | 2012-09-05T05:15:48Z | - |
dc.date.issued | 1991 | en_US |
dc.identifier.citation | Nephron, 1991, v. 59 n. 3, p. 434-439 | en_US |
dc.identifier.issn | 0028-2766 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/161884 | - |
dc.description.abstract | Single graded doses of 1,25-dihydroxycholecalciferol of 2 and 4 μg were added intraperitoneally into the overnight 1.5% glucose dialysate of 6 patients on continuous ambulatory peritoneal dialysis. The effect on peritoneal macrophage chemotaxis and random migration was studied and compared with the baseline when no 1,25-(OH)2D3 was added. No consistent effect on peritoneal macrophage chemotaxis was observed. Random migration was significantly depressed at 4 μg when compared with baseline (5.4 ± 1.9 vs. 12.2 ± 3.7 cells/high-power field, p < 0.05). The potential clinical role of 1,25-(OH)2D3 as an immune modulator requires further study. | en_US |
dc.language | eng | en_US |
dc.publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/NEF | en_US |
dc.relation.ispartof | Nephron | en_US |
dc.subject | 1,25-dihydroxycholecalciferol | - |
dc.subject | peritoneal dialysis | - |
dc.subject | peritoneal macrophage chemotaxis | - |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Calcitriol - Administration & Dosage - Blood - Pharmacology | en_US |
dc.subject.mesh | Cell Movement - Drug Effects | en_US |
dc.subject.mesh | Chemotaxis - Drug Effects | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Injections, Intraperitoneal | en_US |
dc.subject.mesh | Kidney Failure, Chronic - Drug Therapy - Physiopathology - Therapy | en_US |
dc.subject.mesh | Macrophages - Drug Effects - Physiology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Peritoneal Dialysis, Continuous Ambulatory | en_US |
dc.title | 1,25-Dihydroxycholecalciferol and peritoneal macrophage chemotaxis in patients on continuous ambulatory peritoneal dialysis | en_US |
dc.type | Article | en_US |
dc.identifier.email | Ip, MSM:msmip@hku.hk | en_US |
dc.identifier.authority | Ip, MSM=rp00347 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1159/000186604 | - |
dc.identifier.pmid | 1758534 | - |
dc.identifier.scopus | eid_2-s2.0-0025951248 | en_US |
dc.identifier.volume | 59 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.spage | 434 | en_US |
dc.identifier.epage | 439 | en_US |
dc.identifier.isi | WOS:A1991GK33600014 | - |
dc.publisher.place | Switzerland | en_US |
dc.identifier.scopusauthorid | Chan, PCK=7403497841 | en_US |
dc.identifier.scopusauthorid | Ip, MSM=7102423259 | en_US |
dc.identifier.scopusauthorid | Pun, KK=7006538877 | en_US |
dc.identifier.issnl | 0028-2766 | - |